Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma.

Clozel T, Yang S, Elstrom RL, Tam W, Martin P, Kormaksson M, Banerjee S, Vasanthakumar A, Culjkovic B, Scott DW, Wyman S, Leser M, Shaknovich R, Chadburn A, Tabbo F, Godley LA, Gascoyne RD, Borden KL, Inghirami G, Leonard JP, Melnick A, Cerchietti L.

Cancer Discov. 2013 Sep;3(9):1002-19. doi: 10.1158/2159-8290.CD-13-0117. Epub 2013 Aug 16.

2.

Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.

Culjkovic B, Borden KL.

J Oncol. 2009;2009:981679. doi: 10.1155/2009/981679. Epub 2009 Dec 13.

3.

Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin.

Assouline S, Culjkovic B, Cocolakis E, Rousseau C, Beslu N, Amri A, Caplan S, Leber B, Roy DC, Miller WH Jr, Borden KL.

Blood. 2009 Jul 9;114(2):257-60. doi: 10.1182/blood-2009-02-205153. Epub 2009 May 11.

4.

Perspectives in PML: a unifying framework for PML function.

Borden KL, Culjkovic B.

Front Biosci (Landmark Ed). 2009 Jan 1;14:497-509. Review.

PMID:
19273081
5.

Ribavirin targets eIF4E dependent Akt survival signaling.

Tan K, Culjkovic B, Amri A, Borden KL.

Biochem Biophys Res Commun. 2008 Oct 24;375(3):341-5. doi: 10.1016/j.bbrc.2008.07.163. Epub 2008 Aug 14.

6.

The eIF4E RNA regulon promotes the Akt signaling pathway.

Culjkovic B, Tan K, Orolicki S, Amri A, Meloche S, Borden KL.

J Cell Biol. 2008 Apr 7;181(1):51-63. doi: 10.1083/jcb.200707018.

7.

Controlling gene expression through RNA regulons: the role of the eukaryotic translation initiation factor eIF4E.

Culjkovic B, Topisirovic I, Borden KL.

Cell Cycle. 2007 Jan 1;6(1):65-9. Epub 2007 Jan 11. Review.

PMID:
17245113
8.

eIF4E is a central node of an RNA regulon that governs cellular proliferation.

Culjkovic B, Topisirovic I, Skrabanek L, Ruiz-Gutierrez M, Borden KL.

J Cell Biol. 2006 Nov 6;175(3):415-26. Epub 2006 Oct 30.

9.

Further evidence that ribavirin interacts with eIF4E.

Kentsis A, Volpon L, Topisirovic I, Soll CE, Culjkovic B, Shao L, Borden KL.

RNA. 2005 Dec;11(12):1762-6. Epub 2005 Oct 26. Review.

10.

Frequency analysis and clinical characterization of different types of spinocerebellar ataxia in Serbian patients.

Dragasević NT, Culjković B, Klein C, Ristić A, Keckarević M, Topisirović I, Vukosavić S, Svetel M, Kock N, Stefanova E, Romac S, Kostić VS.

Mov Disord. 2006 Feb;21(2):187-91.

PMID:
16149098
11.

Population data on 14 STR loci from population of Serbia and Montenegro (new and renewed data).

Keckarević D, Savić D, Keckarević M, Stevanović M, Tarasjev A, Culjković B, Darmati A, Vukosavić S, Romac S.

Forensic Sci Int. 2005 Jul 16;151(2-3):315-6.

PMID:
15939169
12.

eIF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 3'UTR.

Culjkovic B, Topisirovic I, Skrabanek L, Ruiz-Gutierrez M, Borden KL.

J Cell Biol. 2005 Apr 25;169(2):245-56. Epub 2005 Apr 18.

13.

Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap.

Kentsis A, Topisirovic I, Culjkovic B, Shao L, Borden KL.

Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18105-10. Epub 2004 Dec 15.

14.

Prevalence of the fragile X syndrome in Yugoslav patients with non-specific mental retardation.

Major T, Culjkovic B, Stojkovic O, Gucscekic M, Lakic A, Romac S.

J Neurogenet. 2003 Apr-Sep;17(2-3):223-30.

PMID:
14668200
15.

Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis.

Topisirovic I, Guzman ML, McConnell MJ, Licht JD, Culjkovic B, Neering SJ, Jordan CT, Borden KL.

Mol Cell Biol. 2003 Dec;23(24):8992-9002.

16.

SCA2 and SCA3 mutations in young-onset dopa-responsive parkinsonism.

Svetel M, Djarmati A, Dragasević N, Savić D, Culjković B, Romac S, Kostić VS.

Eur J Neurol. 2003 Sep;10(5):597.

PMID:
12940846
17.

Poly(A) tailing of ancient DNA: a method for reproducible microsatellite genotyping.

Culjković B, Savić D, Stojković O, Romac S.

Anal Biochem. 2003 Jul 1;318(1):124-31.

PMID:
12782040
18.

The proline-rich homeodomain protein, PRH, is a tissue-specific inhibitor of eIF4E-dependent cyclin D1 mRNA transport and growth.

Topisirovic I, Culjkovic B, Cohen N, Perez JM, Skrabanek L, Borden KL.

EMBO J. 2003 Feb 3;22(3):689-703.

19.

[Duchenne's and Becker's muscular dystrophy: analysis of phenotype-genotype correlation in 28 patients] ].

Keckarević M, Savić D, Culjković B, Zamurović N, Major T, Keckarević D, Todorović S, Romac S.

Srp Arh Celok Lek. 2002 May-Jun;130(5-6):154-8. Serbian.

20.

Genetic and clinical analysis of spinocerebellar ataxia type 8 repeat expansion in Yugoslavia.

Topisirovic I, Dragasevic N, Savic D, Ristic A, Keckarevic M, Keckarevic D, Culjkovic B, Petrovic I, Romac S, Kostic VS.

Clin Genet. 2002 Oct;62(4):321-4.

PMID:
12372061
21.

Role of SCA2 mutations in early- and late-onset dopa-responsive parkinsonism.

Kock N, Müller B, Vieregge P, Pramstaller PP, Marder K, Abbruzzese G, Martinelli P, Lang AE, Jacobs H, Hagenah J, Harris J, Meija-Santana H, Fahn S, Hedrich K, Kann M, Gehlken U, Culjkovic B, Schwinger E, Wszolek ZK, Zühlke C, Klein C.

Ann Neurol. 2002 Aug;52(2):257-8; author reply 258. No abstract available.

PMID:
12210804
22.

[Analysis of mutations in the chromosome 17p11.2 region in patients with Charcot-Marie-Tooth type 1 disease and in patients with tomaculous neuropathy].

Zamurović N, Milić V, Dacković J, Zamurović D, Culjković B, Parlović S, Apostolski S, Romac S.

Srp Arh Celok Lek. 2002 Mar-Apr;130(3-4):59-63. Serbian.

23.

Mode of inheritance and susceptibility locus for restless legs syndrome, on chromosome 12q.

Kock N, Culjkovic B, Maniak S, Schilling K, Müller B, Zühlke C, Ozelius L, Klein C, Pramstaller PP, Kramer PL.

Am J Hum Genet. 2002 Jul;71(1):205-8; author reply 208. No abstract available.

24.

CTG repeat polymorphism in DMPK gene in healthy Yugoslav population.

Culjković B, Stojković O, Vukosavić S, Savić D, Rakocevic V, Apostolski S, Romac S.

Acta Neurol Scand. 2002 Jan;105(1):55-8.

PMID:
11903110
25.

Is the 31 CAG repeat allele of the spinocerebellar ataxia 1 (SCA1) gene locus non-specifically associated with trinucleotide expansion diseases?

Savić D, Topisirović I, Keckarević M, Keckarević D, Major T, Culjković B, Stojković O, Rakocević-Stojanović V, Mladenović J, Todorović S, Apostolski S, Romac S.

Psychiatr Genet. 2001 Dec;11(4):201-5.

PMID:
11807410
26.

250 CTG repeats in DMPK is a threshold for correlation of expansion size and age at onset of juvenile-adult DM1.

Savić D, Rakocvic-Stojanovic V, Keckarevic D, Culjkovic B, Stojkovic O, Mladenovic J, Todorovic S, Apostolski S, Romac S.

Hum Mutat. 2002 Feb;19(2):131-9.

PMID:
11793472
27.

The status of SCA1, MJD/SCA3, FRDA, DRPLA and MD triplet containing genes in patients with Huntington disease and healthy controls.

Keckarevic D, Culjkovic B, Savic D, Stojkovic O, Kostic V, Vukosavic S, Romac S.

J Neurogenet. 2000 Dec;14(4):257-63.

PMID:
11342385
28.

Comparison of the number of triplets in SCA1, MJD/SCA3, HD, SBMA, DRPLA, MD, FRAXA and FRDA genes in schizophrenic patients and a healthy population.

Culjković B, Stojković O, Savić D, Zamurović N, Nesić M, Major T, Keckarevi D, Romac S, Zamurovi B, Vukosavić S.

Am J Med Genet. 2000 Dec 4;96(6):884-7. No abstract available.

PMID:
11121205
29.

Yugoslav population data on nine STR loci.

Stojković O, Culjković B, Vukosavić S, Romac S.

Forensic Sci Int. 2001 Jan 15;115(3):239-40.

PMID:
11074179
30.

[Comparison of the number of CAG repeats in the gene for androgen receptors in a control Yugoslav population and in patients with schizophrenia].

Zamurović N, Culjković B, Stojković O, Zamurović B, Romac S.

Srp Arh Celok Lek. 2000 Mar-Apr;128(3-4):71-4. Serbian.

PMID:
10932612
31.

Correlation between triplet repeat expansion and computed tomography measures of caudate nuclei atrophy in Huntington's disease.

Culjkovic B, Stojkovic O, Vojvodic N, Svetel M, Rakic L, Romac S, Kostic V.

J Neurol. 1999 Nov;246(11):1090-3.

PMID:
10631644
32.

[Clinico-genetic study of type I spinocerebelllar ataxia].

Svetel M, Culjković B, Sternić N, Dragasević B, Stojković I, Romac S, Kostić VS.

Srp Arh Celok Lek. 1999 May-Jun;127(5-6):157-62. Serbian.

PMID:
10500422
33.

[Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].

Vojvodić N, Culjković B, Romac S, Stojković O, Sternić N, Sokić D, Kostić VS.

Srp Arh Celok Lek. 1998 Mar-Apr;126(3-4):77-82. Serbian.

PMID:
9863360
34.

Improved polymerase chain reaction conditions for quick diagnostics of Huntington disease.

Culjković B, Ruzdijić S, Rakić L, Romac S.

Brain Res Brain Res Protoc. 1997 Dec 1;2(1):44-6.

PMID:
9438070

Supplemental Content

Loading ...
Support Center